Xi Chen Lin
Chief Tech/Sci/R&D Officer bij STRUCTURE THERAPEUTICS INC.
Vermogen: - $ op 30-04-2024
Profiel
Xi Chen Lin is currently the Chief Scientific Officer at Structure Therapeutics, Inc. and also holds a position as General Manager at Shanghai ShouTi Biotechnology Co. Ltd.
Prior to these roles, Dr. Lin worked as the Head-Asia Pacific External Innovation at Novo Nordisk A from 2016 to 2019.
Dr. Lin received an undergraduate degree from Peking University and a doctorate degree from The Pennsylvania State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Xi Chen Lin
| Bedrijven | Functie | Begin |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01-07-2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Chief Executive Officer | - |
Eerdere bekende functies van Xi Chen Lin
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01-07-2019 |
Opleiding van Xi Chen Lin
| Peking University | Undergraduate Degree |
| The Pennsylvania State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
